Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney

Jer-Ming Chang1, Szu-Chia Chen, Jiun-Chi Huang

  • 1Division of Nephrology (J-MC, S-CC, J-CH, H-CC); and Division of Cardiology (H-MS), Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine (J-MC, S-CC, J-CH, H-MS), Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Faculty of Renal Care (J-MC, H-CC); and Faculty of Medicine (S-CC, H-MS), College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Insights

Anemia and left ventricular hypertrophy (LVH) in chronic kidney disease (CKD) patients independently predict faster kidney function decline and higher cardiovascular event risk. Early assessment aids in identifying high-risk individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Anemia is a frequent complication in chronic kidney disease (CKD).
  • Anemia may initiate or accelerate left ventricular hypertrophy (LVH).
  • The independent association of coexisting anemia and LVH with renal function decline and cardiovascular events in CKD patients requires investigation.

Purpose of the Study:

  • To assess if coexisting anemia and LVH are independently associated with the rate of renal function decline in CKD stages 3 to 5.
  • To determine if coexisting anemia and LVH are independently associated with increased cardiovascular events in CKD stages 3 to 5.

Main Methods:

  • Longitudinal study of 415 CKD patients (stages 3-5).
  • Patients classified into 4 groups based on hemoglobin levels and presence/absence of LVH.
  • Renal function change measured by estimated glomerular filtration rate (eGFR) slope; cardiovascular events defined and analyzed using Cox regression.

Main Results:

  • The eGFR slope was significantly lower in patients with both low hemoglobin and LVH compared to other groups (P ≤ 0.031).
  • Coexisting anemia and LVH were independently associated with a 4.269-fold increased risk of cardiovascular events (HR, 4.269; P = 0.011).

Conclusions:

  • The coexistence of anemia and LVH is independently linked to accelerated renal function decline and adverse cardiovascular outcomes in CKD patients.
  • Serum hemoglobin levels and LVH assessment via echocardiography can identify high-risk CKD patients with poor renal and cardiovascular prognosis.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...